Coherus BioSciences Inc (NASDAQ:CHRS)
| 18.33 Delayed Data As of Jan 22 |  +0.34 / +1.89%Today’s Change | 10.86 Today|||52-Week Range 23.03 | +5.47% Year-to-Date |
Latest CHRS News | Press Releases
No recent news for Coherus BioSciences Inc.
Today’s Trading
| Previous close | 17.99 |
| Today’s open | 17.96 |
| Day’s range | 17.72 - 18.38 |
| Volume | 25,182 |
| Average volume (3 months) | 909,964 |
| Market cap | $1.3B |
Data as of 3:59pm ET, 01/22/2021
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +39.83% |
| Earnings growth (next 5 years) | -3.42% |
| Revenue growth (last year) | -- |
| P/E ratio | 8.9 |
| Price/Sales | 3.70 |
| Price/Book | 12.26 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ALECAlector Inc | +0.39 | +2.41% |
| ADVMAdverum Biotechnolog... | -0.03 | -0.22% |
| MRSNMersana Therapeutics... | -0.23 | -1.15% |
| TVTXTravere Therapeutics... | +0.75 | +2.79% |
Data as of 4:00pm ET, 01/22/2021
Financials
| Next reporting date | March 4, 2021 |
| EPS forecast (this quarter) | $0.21 |
| Annual revenue (last year) | $356.1M |
| Annual profit (last year) | $89.8M |
| Net profit margin | 25.23% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Redwood City, California |
Forecasts
